Modulation of drug-induced apoptosis in a human B-lymphoma cell line (HT58)

Immunol Lett. 1995 Nov;48(1):17-21. doi: 10.1016/0165-2478(95)02434-4.

Abstract

The cytotoxic effect of etoposide (ETO), a topoisomerase II inhibitor, and staurosporine (STA), a non-selective protein kinase inhibitor, were studied on a human lymphoma cell line of B-cell origin (HT58). Apoptosis, induced dose dependently by both drugs, was accompanied with nucleosomal DNA fragmentation detected by flow cytometry. On the other hand, induction of cell death failed using phorbol ester (PMA), anti-IgM antibody (a-IgM) or dexamethasone (DEX), although, all of these agents arrested the cells in G1. Furthermore, PMA pretreatment retarded ETO-induced apoptosis, but enhanced STA cytotoxicity. DEX increased the sensitivity of cells to STA, but did not to ETO. Activity of STA or DEX was only slightly modified by a-IgM pretreatment. The results support the possibility that different apoptotic pathways exist in HT58 cells. The differences in pathways could be manifested either in the signaling routes, or in the molecular effectors of apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / pharmacology*
  • Antibodies, Anti-Idiotypic / pharmacology
  • Apoptosis / drug effects*
  • DNA Damage
  • Dexamethasone / pharmacology
  • Dose-Response Relationship, Drug
  • Etoposide / pharmacology*
  • Flow Cytometry
  • Humans
  • Immunoglobulin M / immunology
  • Lymphoma, B-Cell / pathology*
  • Staurosporine
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tumor Cells, Cultured

Substances

  • Alkaloids
  • Antibodies, Anti-Idiotypic
  • Immunoglobulin M
  • Etoposide
  • Dexamethasone
  • Staurosporine
  • Tetradecanoylphorbol Acetate